Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This is the title of a recent editorial in one of the world’s leading cardiology journals, European Heart Journal, which describes the work of Ming Lei, Derek Terrar and their colleagues. The editorial refers to their article published in 2018 in Circulation that was the subject of an item in our Recent Discoveries section (https://pharm.ox.ac.uk/discoveries). The editorial points out that almost 4 million people in the world die each year from cardiac arrhythmias and that there is currently a mismatch between basic research studies and translation into drugs used in clinical practice. As Lei says ‘this has led to a loss of confidence in both existing

and potential future antiarrhythmic drugs by both clinicians and pharmaceutical companies’. Lei’s article set out to correct this mismatch and to update the famous classification of anti-arrhythmic drugs introduced 50 y ago by two former members of the Department, Vaughan-Williams and Singh. The review in Circulation was an instant ‘hit’ being in the top 5% of research outputs scored by Altimetric and has been downloaded from the journal web site nearly 15,000 times. The authors hope that the review will encourage rational clinical use of existing available anti-arrhythmic drugs in relationship to their particular mechanisms of action, thus optimizing treatment decisions, and prompting new strategies in current clinical practice. They also hope it will promote the discovery of future drugs and therapies for managing cardiac arrhythmias, so improving clinical practice. The editorial can be found at https://doi.org/10.1093/eurheartj/ehz063

Similar stories

Consequences of Tau pathology on hippocampal pyramidal neurons and network activity in ageing mice

Pathological hyperphosphorylated forms of the microtubule-associated binding protein Tau (pTau) are commonly found in people with neurodegenerative diseases, including Alzheimer’s disease, Corticobasal degeneration, and Progressive supranuclear palsy.

Welcome to the 2022/23 academic year in Pharmacology!

At the start of this year, we have welcomed 23 new MSc in Pharmacology students, 13 new MSc(Res) and DPhil students and around a dozen additional project and visiting students from other Departments and other Universities. Some of these new starters joined existing staff, students and visitors in the Department for the first of a series of group photographs, to be taken every 6 months for our archives.

New Platt group paper explores links between Mycobacteria tuberculosis and Niemann-Pick Type C disease

Congratulations to Yuzhe Weng, a DPhil student in the Platt lab, who is first author on new paper published by the group in Nature Communications. Mycobacteria tuberculosis (Mtb), the causative agent of tuberculosis (TB), has the ability to invade, persist and replicate within host cells, which is key to its success as a pathogen. However, the mechanisms that underlie this strategy remain poorly defined.

PROFESSOR REBECCA SITSAPESAN 1959-2022

We were sad to learn that our dear colleague Rebecca has died just a few days before what would have been her 63rd birthday.

New high-resolution imaging provides clue to SARS-CoV-2 leap to humans

A new paper, published this week in the journal Science, highlights cutting-edge imaging techniques used by the group of Professor Ben Davis to investigate the binding of SARS-CoV-2 to human cells.

Dr Mehmood Khan joins Pharmacology as a Visiting Fellow

We are delighted to announce the appointment of Dr Mehmood Khan as a Visiting Fellow in the Department